190 related articles for article (PubMed ID: 8135145)
21. Elevated serum levels of soluble interleukin 2 receptor, interleukin 2 and neopterin in diffuse and limited scleroderma: effects of chlorambucil.
Clements PJ; Peter JB; Agopian MS; Telian NS; Furst DE
J Rheumatol; 1990 Jul; 17(7):908-10. PubMed ID: 2213757
[TBL] [Abstract][Full Text] [Related]
22. Tumor necrosis factor in solid tumors: increased blood levels in the metastatic disease.
Ardizzoia A; Lissoni P; Brivio F; Tisi E; Perego MS; Grassi MG; Pittalis S; Crispino S; Barni S; Tancini G
J Biol Regul Homeost Agents; 1992; 6(3):103-7. PubMed ID: 1492596
[TBL] [Abstract][Full Text] [Related]
23. Autocrine regulation of macrophage proliferation by tumor necrosis factor-alpha.
Branch DR; Guilbert LJ
Exp Hematol; 1996 May; 24(6):675-81. PubMed ID: 8635522
[TBL] [Abstract][Full Text] [Related]
24. [Mononuclear cell activation in Crohn's disease. Evaluation using serum assay of neopterin and interleukin-2 soluble receptors].
Duclos B; Reimund JM; Lang JM; Coumaros G; Chamouard P; Lehr L; Baumann R; Koehl C; Weill JP
Gastroenterol Clin Biol; 1990; 14(1):22-7. PubMed ID: 2311849
[TBL] [Abstract][Full Text] [Related]
25. Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study.
Schiller JH; Hank JA; Khorsand M; Storer B; Borchert A; Huseby-Moore K; Burns D; Wesly O; Albertini MR; Wilding G; Sondel PM
Clin Cancer Res; 1996 Feb; 2(2):319-30. PubMed ID: 9816175
[TBL] [Abstract][Full Text] [Related]
26. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
27. Clinical value of soluble interleukin-2 receptor in infectious complications.
Iwagaki H; Hizuta A; Iwadou H; Perdomo JA; Tanaka N; Orita K
Acta Med Okayama; 1994 Aug; 48(4):225-6. PubMed ID: 7817778
[TBL] [Abstract][Full Text] [Related]
28. Differential early posttransplant cytokine responses in living and cadaver donor renal allografts.
Sadeghi M; Daniel V; Weimer R; Wiesel M; Hergesell O; Opelz G
Transplantation; 2003 Apr; 75(8):1351-5. PubMed ID: 12717229
[TBL] [Abstract][Full Text] [Related]
29. Effect of granulocyte-macrophage colony-stimulating factor on the immune response of circulating monocytes after severe trauma.
Flohé S; Lendemans S; Selbach C; Waydhas C; Ackermann M; Schade FU; Kreuzfelder E
Crit Care Med; 2003 Oct; 31(10):2462-9. PubMed ID: 14530752
[TBL] [Abstract][Full Text] [Related]
30. Treatment with tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor increases epidermal Langerhans' cell numbers in cancer patients.
Janik JE; Miller LL; Kopp WC; Taub DD; Dawson H; Stevens D; Kostboth P; Curti BD; Conlon KC; Dunn BK; Donegan SE; Ullrich R; Alvord WG; Gause BL; Longo DL
Clin Immunol; 1999 Dec; 93(3):209-21. PubMed ID: 10600331
[TBL] [Abstract][Full Text] [Related]
31. The effect of granulocyte macrophage-colony stimulating factor on bacterial translocation after administration of 5-fluorouracil in rats.
Kucuk C; Ozkan M; Akgun H; Muhtaroglu S; Sozuer E
J Surg Res; 2005 Sep; 128(1):15-20. PubMed ID: 15975592
[TBL] [Abstract][Full Text] [Related]
32. Production of granulocyte colony stimulating factor, granulocyte macrophage colony stimulating factor, and tumor necrosis factor alpha during remission and infections in patients with acute leukemia.
Duru F; Ertem U; Taçyildiz N; Kirazli S
J Med; 1995; 26(5-6):241-52. PubMed ID: 8721901
[TBL] [Abstract][Full Text] [Related]
33. ONO-4007, an antitumor lipid A analog, induces tumor necrosis factor-alpha production by human monocytes only under primed state: different effects of ONO-4007 and lipopolysaccharide on cytokine production.
Matsumoto N; Aze Y; Akimoto A; Fujita T
J Pharmacol Exp Ther; 1998 Jan; 284(1):189-95. PubMed ID: 9435177
[TBL] [Abstract][Full Text] [Related]
34. In vitro modulatory effects of interleukin-3 on macrophage activation induced by interleukin-2.
Lissoni P; Pittalis S; Brivio F; Tisi E; Rovelli F; Ardizzoia A; Barni S; Tancini G; Giudici G; Biondi A
Cancer; 1993 Mar; 71(6):2076-81. PubMed ID: 8443757
[TBL] [Abstract][Full Text] [Related]
35. Acute effect of hemodialysis on serum levels of the proinflammatory cytokines.
Tarakçioğlu M; Erbağci AB; Usalan C; Deveci R; Kocabaş R
Mediators Inflamm; 2003 Feb; 12(1):15-9. PubMed ID: 12745544
[TBL] [Abstract][Full Text] [Related]
36. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
Elg SA; Hill RB; Heldman L; Ramakrishnan S
Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933
[TBL] [Abstract][Full Text] [Related]
37. Cytokines (IL-6, TNF-alpha, IL-1alpha) and soluble interleukin-2 receptor as serum tumor markers in multiple myeloma.
Filella X; Blade J; Guillermo AL; Molina R; Rozman C; Ballesta AM
Cancer Detect Prev; 1996; 20(1):52-6. PubMed ID: 8907203
[TBL] [Abstract][Full Text] [Related]
38. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
Naumnik W; Chyczewska E; Kovalchuk O; Tałałaj J; Izycki T; Panek B
Rocz Akad Med Bialymst; 2004; 49():246-51. PubMed ID: 15631351
[TBL] [Abstract][Full Text] [Related]
39. Pilot study of natural human interleukin-2 in patients with chronic hepatitis B. Immunomodulatory and antiviral effects.
Tilg H; Vogel W; Tratkiewicz J; Aulitzky WE; Herold M; Gruber M; Geissler D; Umlauft F; Judmaier G; Schwulera U
J Hepatol; 1993 Sep; 19(2):259-67. PubMed ID: 8301059
[TBL] [Abstract][Full Text] [Related]
40. [Relation of serum levels of the soluble cytoadhesion molecules sVCAM-1 and sICAM-1 to selected factors in the cytokine network in multiple myeloma].
Scudla V; Budíková M; Bacovský J; Opíchalová D; Farbiaková V
Cas Lek Cesk; 2000 Jul; 139(13):401-6. PubMed ID: 10971970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
